Paper16136646
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.
Di Bisceglie AM and 14 others. J Hepatol, 2005. Cited by 260 papers, by iCite.
Cite this record
ConductScience Library. Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial. Papers, record 16136646. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16136646
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.
- PubMed
- Publication types
- Clinical Trial, Controlled Clinical Trial, Journal Article, Multicenter Study, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hepatitis C | Major topic |
| alpha-Fetoproteins | Major topic |
| Alanine Transaminase | |
| Aspartate Aminotransferases | |
| Biomarkers | |
| Female | |
| Humans | |
| Liver Cirrhosis | |
| Liver Function Tests | |
| Male | |
| Middle Aged |
Source PubMed
Grants20
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| M01RR-00042 | NCRR NIH HHS | United States | M01RR000042 | PubMed and NIH | NIH RePORTER |
| M01RR-00043 | NCRR NIH HHS | United States | M01RR000043 | PubMed and NIH | NIH RePORTER |
| M01RR-00051 | NCRR NIH HHS | United States | M01RR000051 | PubMed and NIH | NIH RePORTER |
| M01RR-00065 | NCRR NIH HHS | United States | M01RR000065 | PubMed and NIH | NIH RePORTER |
| M01RR-00633 | NCRR NIH HHS | United States | M01RR000633 | PubMed and NIH | NIH RePORTER |
| M01RR-00827 | NCRR NIH HHS | United States | M01RR000827 | PubMed and NIH | NIH RePORTER |
| M01RR-01066 | NCRR NIH HHS | United States | M01RR001066 | PubMed and NIH | NIH RePORTER |
| M01RR-06192 | NCRR NIH HHS | United States | M01RR006192 | PubMed and NIH | NIH RePORTER |
| N01--DK-9-2326 | NIDDK NIH HHS | United States | N01DK092326 | PubMed and NIH | NIH RePORTER |
| N01-DK-9-2318 | NIDDK NIH HHS | United States | N01DK092318 | PubMed and NIH | NIH RePORTER |
| N01-DK-9-2319 | NIDDK NIH HHS | United States | N01DK092319 | PubMed and NIH | NIH RePORTER |
| N01-DK-9-2320 | NIDDK NIH HHS | United States | N01DK092320 | PubMed and NIH | NIH RePORTER |
| N01-DK-9-2321 | NIDDK NIH HHS | United States | N01DK092321 | PubMed and NIH | NIH RePORTER |
| N01-DK-9-2322 | NIDDK NIH HHS | United States | N01DK092322 | PubMed and NIH | NIH RePORTER |
| N01-DK-9-2323 | NIDDK NIH HHS | United States | N01DK092323 | PubMed and NIH | NIH RePORTER |
| N01-DK-9-2324 | NIDDK NIH HHS | United States | N01DK092324 | PubMed and NIH | NIH RePORTER |
| N01-DK-9-2325 | NIDDK NIH HHS | United States | N01DK092325 | PubMed and NIH | NIH RePORTER |
| N01-DK-9-2327 | NIDDK NIH HHS | United States | N01DK092327 | PubMed and NIH | NIH RePORTER |
| N01-DK-9-2328 | NIDDK NIH HHS | United States | N01DK092328 | PubMed and NIH | NIH RePORTER |
| Z01DK075009 | NIH | NIH RePORTER |
Cited by162
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 260 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42424119 | Transformation Discriminant Analysis for Constructing Optimal Biomarker Combinations. | Stat Med | 2026 | https://conductscience.org/library/papers/42424119 | PubMed |
| 42016288 | High Expression of Follistatin is a Risk Factor Predicting Poor Overall Survival in Hepatocellular Carcinoma Patients. | J Hepatocell Carcinoma | 2026 | https://conductscience.org/library/papers/42016288 | PubMed |
| 41575695 | Assessment circulating micro-RNA-192 in Egyptian patients with non-viral liver cirrhosis and hepatocellular carcinoma. | Discov Oncol | 2026 | https://conductscience.org/library/papers/41575695 | PubMed |
| 41298250 | Aptamer Engineering: Strategies for Discovering Functional Nucleic Acids for Next-Generation Diagnostics and Biosensing. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41298250 | PubMed |
| 41293148 | Pembrolizumab combined with surgical treatment for spontaneously ruptured undifferentiated pleomorphic sarcoma of the liver: a case report and literature review. | Front Immunol | 2025 | https://conductscience.org/library/papers/41293148 | PubMed |
| 41147778 | Unstable Recompensation: An Intermediate Subtype in Patients With HBV-Related Decompensated Cirrhosis. | Aliment Pharmacol Ther | 2026 | https://conductscience.org/library/papers/41147778 | PubMed |
| 40897738 | Normalization of serum alpha fetoprotein after direct acting antivirals in hepatitis C patients lowers hepatocellular carcinoma risk. | Sci Rep | 2025 | https://conductscience.org/library/papers/40897738 | PubMed |
| 40786815 | Contemporary epidemiology of hepatocellular carcinoma: understanding risk factors and surveillance strategies. | J Can Assoc Gastroenterol | 2024 | https://conductscience.org/library/papers/40786815 | PubMed |
| 40487934 | Diagnostic value of alpha-fetoprotein and prothrombin induced by vitamin K absence-II in serum, bile, and feces in hepatocellular carcinoma. | World J Gastrointest Oncol | 2025 | https://conductscience.org/library/papers/40487934 | PubMed |
| 40410719 | Emerging roles of non-coding RNA derived from extracellular vesicles in regulating PD-1/PD-L1 pathway: insights into cancer immunotherapy and clinical applications. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/40410719 | PubMed |
| 40384539 | Assisting the Diagnosis of Cirrhosis in Chronic Hepatitis C Patients Based on Machine Learning Algorithms: A Novel Non-Invasive Approach. | J Clin Lab Anal | 2025 | https://conductscience.org/library/papers/40384539 | PubMed |
| 40282551 | Astrocyte Elevated Gene-1/Metadherin (AEG-1/MTDH): A Promising Molecular Marker and Therapeutic Target for Hepatocellular Carcinoma. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40282551 | PubMed |
| 39925090 | A concise review of updated global guidelines for the management of hepatocellular carcinoma: 2017-2024. | J Liver Cancer | 2025 | https://conductscience.org/library/papers/39925090 | PubMed |
| 39751721 | Diagnostic Value of Circulating microRNAs for Hepatocellular Carcinoma: Results of a Meta-analysis and Validation. | Biochem Genet | 2026 | https://conductscience.org/library/papers/39751721 | PubMed |
| 39108278 | Redefining HCC Surveillance in India: A Call for Innovative and Inclusive Strategies. | J Clin Exp Hepatol | 2024 | https://conductscience.org/library/papers/39108278 | PubMed |
| 38549786 | Development of a Reliable GADSAH Model for Differentiating AFP-negative Hepatic Benign and Malignant Occupying Lesions. | J Hepatocell Carcinoma | 2024 | https://conductscience.org/library/papers/38549786 | PubMed |
| 38279264 | Combinatorial Gene Expression Profiling of Serum HULC, HOTAIR, and UCA1 lncRNAs to Differentiate Hepatocellular Carcinoma from Liver Diseases: A Systematic Review and Meta-Analysis. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38279264 | PubMed |
| 38196529 | Exploring HMGB2 in hepatocellular carcinoma: charting new paths for diagnostic and therapeutic innovations. | J Gastrointest Oncol | 2023 | https://conductscience.org/library/papers/38196529 | PubMed |
| 38187811 | A case report of challenges in distinguishing gastroesophageal junction hepatoid adenocarcinoma from testicular germ cell tumor: Insights for improved diagnosis with gene expression profiling. | SAGE Open Med Case Rep | 2024 | https://conductscience.org/library/papers/38187811 | PubMed |
| 38076360 | NAFLD and NAFLD-related HCC in Asia: Burden and Surveillance. | J Clin Exp Hepatol | 2024 | https://conductscience.org/library/papers/38076360 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AFP | 174 | PubTator's text mining | https://conductscience.org/library/genes/174 | NCBI Gene |
| SLC17A5 | 26503 | PubTator's text mining | https://conductscience.org/library/genes/26503 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16136646
GET https://conductscience.org/api/papers/v1/16136646/cited_by?page=2